| 000 | 01585 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517002626.0 | ||
| 264 | 0 | _c20150914 | |
| 008 | 201509s 0 0 eng d | ||
| 022 | _a1872-213X | ||
| 024 | 7 |
_a10.2174/1872213x08666141113154814 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKrásny, Jan | |
| 245 | 0 | 0 |
_aThe role of Chlamydia pneumoniae in the etiology of keratoconjunctivitis sicca (KCS). _h[electronic resource] |
| 260 |
_bRecent patents on inflammation & allergy drug discovery _c2014 |
||
| 300 |
_a216-22 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntibodies, Bacterial _xisolation & purification |
| 650 | 0 | 4 |
_aAzithromycin _xtherapeutic use |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aChlamydia Infections _xcomplications |
| 650 | 0 | 4 |
_aChlamydophila pneumoniae _xisolation & purification |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin A _ximmunology |
| 650 | 0 | 4 |
_aImmunoglobulin M _ximmunology |
| 650 | 0 | 4 |
_aKeratoconjunctivitis Sicca _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPatents as Topic |
| 700 | 1 | _aHrubá, Dana | |
| 700 | 1 | _aNetuková, Magdalena | |
| 773 | 0 |
_tRecent patents on inflammation & allergy drug discovery _gvol. 8 _gno. 3 _gp. 216-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1872213x08666141113154814 _zAvailable from publisher's website |
| 999 |
_c24352882 _d24352882 |
||